Latest Articles
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - NewsBreak
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS NewsBreak
Published: March 13, 2025, 5:37 a.m.
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - newsbreak.com
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS newsbreak.com
Published: March 13, 2025, 5:37 a.m.
Breakthrough for endometriosis sufferers as new pill to be available on NHS - The Independent
Breakthrough for endometriosis sufferers as new pill to be available on NHS The Independent
Published: March 13, 2025, 5:37 a.m.
Kerry hotel plays host to second annual Cneasu Endometriosis Inspired Women’s Health Retreat - Irish Independent
Kerry hotel plays host to second annual Cneasu Endometriosis Inspired Women’s Health Retreat Irish Independent
Published: March 13, 2025, 4 a.m.
'First-of-a-kind' endometriosis tablet approved for use on NHS - This is the Coast
'First-of-a-kind' endometriosis tablet approved for use on NHS This is the Coast
Published: March 13, 2025, 3:01 a.m.
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - MSN
Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS MSN
Published: March 13, 2025, 1:21 a.m.
Let’s Talk About It, Period: Could non-invasive test revolutionize endometriosis diagnosis? - Global News Kingston
Let’s Talk About It, Period: Could non-invasive test revolutionize endometriosis diagnosis? Global News Kingston
Published: March 12, 2025, 10:30 p.m.
Harvard doctors sue Trump admin for removing LGBTQ+ health research - MassLive.com
Harvard doctors sue Trump admin for removing LGBTQ+ health research MassLive.com
Published: March 12, 2025, 8:47 p.m.
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire
Published: March 12, 2025, 5:34 p.m.
S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer - Medscape
S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer Medscape
Published: March 12, 2025, 4:51 p.m.
Link copied to clipboard!